These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10953659)

  • 21. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genealogy and the clinical manifestations of familial hyperlipidemias types IIa and IIb].
    Lipovetskiĭ BM
    Ter Arkh; 1993; 65(12):34-8. PubMed ID: 8146768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL; Van Acker P; Tan H; Deslypere JP
    Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children.
    Ose L
    Semin Vasc Med; 2004 Feb; 4(1):51-7. PubMed ID: 15199433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic procedures.
    Thomas HP; Vogt A; Wilund KR; Schliesser C; Steinhagen-Thiessen E; Kassner U
    Ther Apher Dial; 2004 Aug; 8(4):275-80. PubMed ID: 15274677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
    Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
    Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of therapy with simvastatin 80 mg and 120 mg in patients with familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Chik G
    Int J Clin Pract; 2001 Dec; 55(10):673-5. PubMed ID: 11777291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Family and polygenic hypercholesteremia: similarities and differencies according to long-term clinical observations].
    Lipovetskiĭ BM
    Ter Arkh; 2009; 81(1):61-4. PubMed ID: 19253714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory-based assessment of plasma lipids and lipoproteins for the classification of familial hypercholesterolemic and hypertriglyceridemic states.
    Demacker PN
    Semin Vasc Med; 2004 Feb; 4(1):13-22. PubMed ID: 15199429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoin.
    Tomlinson B; Chan JC; Chan WB; Chen WW; Chow FC; Li SK; Kong AP; Ma RC; Siu DC; Tan KC; Wong LK; Yeung VT; But BW; Cheung PT; Fu CC; Tung JY; Wong WC; Yau HC
    Hong Kong Med J; 2018 Aug; 24(4):408-415. PubMed ID: 30100583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia.
    Pitsavos C; Choumerianou DM; Skoumas J; Maumus S; Stefanadis C; Dedoussis GV; Visvikis-Siest S
    Clin Exp Med; 2005 Dec; 5(4):196-201. PubMed ID: 16362800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis, clinical features and treatment of hyperlipidemias in children].
    Widhalm K
    Monatsschr Kinderheilkd; 1982 Oct; 130(10):747-52. PubMed ID: 7177116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of heterozygous familial hypercholesterolaemia in children.
    Nicholls DP; Cather M; Byrne C; Graham CA; Young IS
    Int J Clin Pract; 2008 Jul; 62(7):990-4. PubMed ID: 18492057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for familial hypercholesterolaemia. Early identification and treatment of patients is important.
    Nicholls P; Young I; Lyttle K; Graham C
    BMJ; 2001 Apr; 322(7293):1062. PubMed ID: 11349661
    [No Abstract]   [Full Text] [Related]  

  • 38. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
    J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe coronary artery disease in premenopausal woman with familial hypercholesterolaemia].
    Roszczyk N; Wierzbowska-Drabik K; Kręcki R; Kasprzak JD
    Kardiol Pol; 2013; 71(5):505-8. PubMed ID: 23788092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnosis of familial hypercholesterolaemia.
    Graham CA; Latten MJ; Hart PJ
    Curr Opin Lipidol; 2017 Aug; 28(4):313-320. PubMed ID: 28463860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.